HallA.K., BehrmannH.R.Prostaglandins: biosynthesis, metabolism and mechanism of cellular action. In: LeeJ.B., ed. Prostaglandins, (Alvioli LV, Ed. Current Endocrinology)New York: Elsevier, 1982; 1–38.
2.
SamuelssonB.Leukotrienes and related compounds. In: HayaishiO., YamamotoS., eds. Kyoto Conference on Prostaglandins. Advances in Prostaglandin, Thomboxane and Leukotriene Research.New York: Raven Press, 1985; 15: 1–9.
3.
MantovaniE., MarconiW., CeboB., TognaA.R., TognaG., CaprinoL.A native whole blood test for the evaluation of blood-surface interaction: determination of thromboxane production.Int J Artif Organs1984; 7: 147–50.
4.
SchultzeG., WagnerK., NeumayerH-H, FitznerR., MolzahnM.Effect of dialyzer membranes on in vitro generation of eicosanoids.Int J Artif Organs1987; 10: 275–8.
5.
BetzM., HaenschG-M, RauterbergE-W, BommerJ., RitzE.Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement.Kidney Int1988; 34: 67–71.
6.
TettaC., JeantetA., CamussiG.Direct interaction between polymorphonuclear neutrophils and cuprophane membranes in a plasma-free model of dialysis.Proc EDTA-ERA1984; 21: 150–5.
7.
SchultzeG., WagnerK., NeumayerH-H, MolzahnM.Eicosanoid release as an indicator of membrane bio-compatibility.Contr Nephrol Basel: Karger1987; 59: 44–50.
8.
BommerJ., GemsaD., WaldherrR., KesslerJ., RitzE.Plastic filing from dialysis tubing induces prostanoid release from macrophages.Kidney Int1984; 26: 331–7.
9.
SmithM., DunnM.Impaired platelet thromboxane production in renal failure.Nephron1981; 29: 133–7.
BloomA., GreavesM., PrestonF.E., BrownC.B.Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.Brit J Haematol1986; 62: 143–9.
12.
KyrleP.A., StockenhuberF., BrennerB.Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet α granule release in chronic renal failure.Thromb Haemostas1988; 60: 205–8.
13.
MahioutA., JörresA., MeinholdH., KesselM.Prostaglandin production and extracorporeal complement activation by dialyzer membranes.Trans Am Soc Artif Intern Organs1986; 32: 88–92.
14.
MahioutA., MeinholdH., KesselM., SchulzeH., BaurmeisterU.Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.Artificial Organs1987; 11: 149–54.
15.
LeithnerC., SinzingerH., SilberbauerK., StummvollH.K.Platelets, microaggregates and release of endogenous prostacyclin during the initial phase of hemodialysis.Proc EDTA1981; 18: 122–5.
16.
YlikorkalaO., HuttunenK., JärviJ., ViinikkaL.Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.Clin Nephrol1982; 18: 83–7.
17.
SchultzeG., NeumayerH-H, WagnerK., MolzahnM.Der Einfluss des Prostaglandinsystems auf das Kreislaufverhalten während Hämodialyse.Nieren Hochdruckkrankheiten1984; 13: 179–85.
18.
MahioutA., JörresA., HissR., MeinholdH., KesselM.Effects of blood-dialyser interaction on prostaglandins in uremic patients and in healthy man.Nephrol Dial Transplant1987; 2: 546–50.
19.
SchmittG.W., MoakeJ.L., RudyC.K., VicksS.L., HamburgerR.J.Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design.Am J Med1987; 83: 411–8.
20.
JorstadS.Biocompatibility of different hemodialysis and plasmapheresis membranes.Blood Purification1987; 5: 123–37.
FoidartJ.B., DavinJ-C, MalaiseM., Saint-RemyM., MahieuP.Stimulation of platelet lipoxygenase during hemodialysis.Kidney Int1988; 33(Suppl 24): S80–1.
23.
UitolaP., SuyesM., HeikkiläH., JalonenJ.Prostanoids and hemodynamics in man before and during cardiopulmonary bypass.Prostaglandins1984; 28: 497–508.
24.
FlemingW.H., SarafianL.B., LeuschenM.P.Serum concentrations of prostacyclin and thromboxane in children before, during, and after cardiopulmonary bypass.J Thorac Cardiovasc Surg1986; 92: 73–8.
25.
BergströmJ.Protein catabolic factors in patients on renal replacement therapy.Blood Purification1985; 3: 215–36.
26.
LamperyS., CarozziS., NasiniM.G.Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD.Trans Am Soc Artif Intern Organs1986; 32: 35–8.
27.
LamperiS., CarozziS.Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.Nephron1986; 44: 219–55.
28.
SteinhauerH.B., SchollmeyerP.Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int1986; 29: 584–90.
29.
FoeghM.L., MaddoxY.T., RamwellP.W.Human peritoneal eosinophils and formation of arachinodate cyclooxygenase products.Scand J Immunol1986; 23: 599–603.
30.
ZijlstraF.J., van den BroekAMWC, VincentJ.E., DiderichPPHM, op de Hoek-FesA.M.C., ClayesM.Formation of leukotriene B4, 20-hydroxy leukotriene B4 and other arachidonic acid metabolites by macrophages during peritonitis in patients with continuous ambulatory peritoneal dialysis.Prostaglandins Leukotrienes Med1987; 27: 151–60.
31.
JensenW., HendersonR., SchulzeH., SchmerG.Hemodynamic measurement in a sheep model with a hollow fiber artificial kidney containing modified cellulose.Life Support Systems1985; 3(Suppl I): 404–8.
32.
StimlerN.P., BachM.K., BloorC.M., HugliT.E.Release of leukotrienes from guinea pig lung stimulated by C5a des Arg Anaphylatoxin.J Immunol1982; 128: 2247–52.
33.
McDonaldJ.W.D., AliM., MorganE., TownsendE.R., CooperJ.D.Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.Circ Res1983; 52: 1–6.
34.
WalkerJ.F., LindsayR.M., SibbaldW.J., LintonA.L.Acute pulmonary hypertension, leukopenia, and hypoxia in early hemodialysis.Proc EDTA-ERA1984; 21: 135–42.
35.
CheungA.K., BaranowskiR.L., WaymanA.L.The role of thromboxane in cuprophan-induced pulmonary hypertension.Kidney Int1987; 31: 1072–9.
BorgesH.F., KjellstrandC.M.The effect of prostaglandin inhibition on the clinical course of chronic hemodialysis.Nephron1986; 42: 120–2
38.
KishimotoT., TeradaT., OkaharaT., AbeT., YamagamiS., MaekawaM.Correlation between blood prostaglandins and blood pressure in chronic renal failure.Nephron1987; 47: 49–55.
39.
RemuzziG., CavenaghiA., MeccaG., DonatiM.Prostacyclin-like activity and bleeding in renal failure.Lancet1977; ii: 1195–7.
40.
KotP.A., FitzpatrickT.M.Cardiovascular actions of prostaglandin precursors and selected prostanoic compounds. In: LeeJ.B., ed. Prostaglandins.New York: Elsevier, (Current Endocrinology)1982; 177–213.
41.
AttallahA.A., LeeJ.B.Prostaglandins, renal function, and blood pressure regulation. In: LeeJ.B., ed. Prostaglandins.New York: Elsevier, (Alvioli LV, ed. Current Endocrinology)1982; 251–301.
42.
FeuersteinG.Cardiac and vascular effects of leukotrienes. In: ZorU., NaorZ., KohenF., eds. Leukotrienes and prostanoids in health and disease. Advances in Prostaglandin, Thromboxane, and Leukotriene Research.New York: Raven Press, 1986; 16: 299–308.
43.
VaggeR., CavatortaF., QueiroloC., RosselliP., GentileA., BertullaA.Hemodynamic changes during acetate dialysis, bicarbonate dialysis, and hemofiltration.Blood Purification1988; 6: 43–50.
44.
NigamS., BeckerR., RosendahlU.The concentrations of 6-keto-PGF1 and TXB2 in plasma samples from patients with benign and malignant tumours of the breast.Prostaglandins1985; 29: 513–28.
45.
GranströmE., KumlinM.Assay of thromboxane production in biological systems: reliability of TXB2 versus 11-dehydro-TXB2 as targets for measurement. In: SamuelssonB., PaolettiR., RamwellP.W., eds. Prostaglandins and related compounds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research.New York: Raven Press, 1987; 17: 587–94.
46.
LecompteT., NicolasP., MamasS., DrayF.Radioimmunoassay for 11-dehydro-thromboxane B2 using an iodinated ligand: preliminary applications to human fluids. In: SamuelssonB., PaolettiR., RamwellP.W., eds. Prostaglandins and Related Compounds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research.New York: Raven Press1987; 17: 595–7.